Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Goebell

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
Human Vaccines & Immunotherapeutics|April 28, 2015
Checkpoint modulation--A new way to direct the immune system against renal cell carcinomaJens Bedke, Stephan Kruck, Georgios Gakis, et al.
Urologie (Heidelberg, Germany)|May 19, 2025
[PSA in the extreme range-an expression of an unfavorable prognosis? : A review of course and treatment of prostate cancer with prostate-specific antigen (PSA) values in the three-to-four-digit range]Christian Dirscherl, Thomas Ebert, Bernd J Schmitz-Dräger, et al.
Urologia Internationalis|February 14, 2015
Testosterone Replacement Therapy in Hypogonadal Men Following Prostate Cancer Treatment: A Questionnaire-Based Retrospective Study among Urologists in Bavaria, GermanyCharlotte Marie Kühn, Hans Strasser, Alexander Romming, et al.
BJU International|November 12, 2024
Real-world use of androgen-deprivation therapy intensification for metastatic hormone-sensitive prostate cancer: a systematic reviewAmit D Raval, Stephanie Chen, Natasha Littleton, et al.
Urologie (Heidelberg, Germany)|August 29, 2024
[Androgen deprivation as initial and backbone therapy for prostate carcinoma cancer : A retrospective data analysis from urological practices in Germany]Peter J Goebell, Felix Cornelius, Annika Fernandez Milano, et al.
World Journal of Urology|December 23, 2003
Environmental exposure, chlorinated drinking water, and bladder cancerPeter J Goebell, Cristina M Villanueva, Albert W Rettenmeier, et al.
Urologic Oncology|July 13, 2023
Sarcopenia assessments as predictors of overall survival in patients with metastatic renal cell carcinomaLuca Kümmerl, Matthias Kraulich, Wladimir Lesyuk, et al.
Clinical Genitourinary Cancer|November 2, 2015
A Cross-Sectional Investigation of Fatigue, Mucositis, Hand-Foot Syndrome and Dysgeusia in Advanced Renal Cell Carcinoma Treatment: Final Results From the FAMOUS StudyPeter J Goebell, Lothar Müller, Hans-Jürgen Hurtz, et al.
Urologic Oncology|July 9, 2010
The International Bladder Cancer NetworkH Barton Grossman, Colin P N Dinney, Bernd J Schmitz-Dräger, et al.
BMJ Open|August 18, 2016
Assessment of the extent of unpublished studies in prognostic factor research: a systematic review of p53 immunohistochemistry in bladder cancer as an examplePeggy Sekula, Julia B Pressler, Willi Sauerbrei, et al.
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
Human Vaccines & Immunotherapeutics|April 28, 2015
Checkpoint modulation--A new way to direct the immune system against renal cell carcinomaJens Bedke, Stephan Kruck, Georgios Gakis, et al.
Urologie (Heidelberg, Germany)|May 19, 2025
[PSA in the extreme range-an expression of an unfavorable prognosis? : A review of course and treatment of prostate cancer with prostate-specific antigen (PSA) values in the three-to-four-digit range]Christian Dirscherl, Thomas Ebert, Bernd J Schmitz-Dräger, et al.
Urologia Internationalis|February 14, 2015
Testosterone Replacement Therapy in Hypogonadal Men Following Prostate Cancer Treatment: A Questionnaire-Based Retrospective Study among Urologists in Bavaria, GermanyCharlotte Marie Kühn, Hans Strasser, Alexander Romming, et al.
BJU International|November 12, 2024
Real-world use of androgen-deprivation therapy intensification for metastatic hormone-sensitive prostate cancer: a systematic reviewAmit D Raval, Stephanie Chen, Natasha Littleton, et al.
Urologie (Heidelberg, Germany)|August 29, 2024
[Androgen deprivation as initial and backbone therapy for prostate carcinoma cancer : A retrospective data analysis from urological practices in Germany]Peter J Goebell, Felix Cornelius, Annika Fernandez Milano, et al.
World Journal of Urology|December 23, 2003
Environmental exposure, chlorinated drinking water, and bladder cancerPeter J Goebell, Cristina M Villanueva, Albert W Rettenmeier, et al.
Urologic Oncology|July 13, 2023
Sarcopenia assessments as predictors of overall survival in patients with metastatic renal cell carcinomaLuca Kümmerl, Matthias Kraulich, Wladimir Lesyuk, et al.
Clinical Genitourinary Cancer|November 2, 2015
A Cross-Sectional Investigation of Fatigue, Mucositis, Hand-Foot Syndrome and Dysgeusia in Advanced Renal Cell Carcinoma Treatment: Final Results From the FAMOUS StudyPeter J Goebell, Lothar Müller, Hans-Jürgen Hurtz, et al.
Urologic Oncology|July 9, 2010
The International Bladder Cancer NetworkH Barton Grossman, Colin P N Dinney, Bernd J Schmitz-Dräger, et al.
BMJ Open|August 18, 2016
Assessment of the extent of unpublished studies in prognostic factor research: a systematic review of p53 immunohistochemistry in bladder cancer as an examplePeggy Sekula, Julia B Pressler, Willi Sauerbrei, et al.
Pageof 11